Who
Katie Peng
Director
Company insider
Files Form 4 as: Director, Scholar Rock Holding; Director, Adicet Bio.
In numbers
- Trades disclosed
- 34
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $795K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 10 Jul 2023
- Last trade
- 1 Jul 2026
- Last filed
- 6 Jul 2026
Companies traded
Activity over time
1 Mar 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 6 Jul 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $160K2,988 at $53.56 | filing |
| 1 Jul 2026filed 6 Jul 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $132K2,437 at $54.25 | filing |
| 1 Jul 2026filed 6 Jul 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $1,15421 at $54.96 | filing |
| 1 Jul 2026filed 6 Jul 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $160K2,988 at $53.56 | filing |
| 1 Jul 2026filed 6 Jul 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $132K2,437 at $54.25 | filing |
| 1 Jul 2026filed 6 Jul 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $1,15421 at $54.96 | filing |
| 21 Jun 2026filed 23 Jun 2026 | ACET Adicet Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —4,200 at $0.00 | filing |
| 21 Jun 2026filed 23 Jun 2026 | ACET Adicet Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —4,200 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Code A | —6,839 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | SRRK Scholar Rock Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,310 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | SRRK Scholar Rock Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,310 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Code A | —6,839 at $0.00 | filing |
| 16 Dec 2025filed 18 Dec 2025 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $32K726 at $43.88 | filing |
| 16 Dec 2025filed 18 Dec 2025 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $12K280 at $44.63 | filing |
| 16 Sep 2025filed 17 Sep 2025 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $30K930 at $32.48 | filing |
| 16 Sep 2025filed 17 Sep 2025 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $2,52376 at $33.20 | filing |
| 16 Jun 2025filed 17 Jun 2025 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $95K2,977 at $31.96 | filing |
| 16 Jun 2025filed 17 Jun 2025 | SRRK Scholar Rock HoldingBiotechnology | SEC FORM 4 Sold | $1,75754 at $32.53 | filing |
| 11 Jun 2025filed 13 Jun 2025 | ACET Adicet Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —26,400 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | ACET Adicet BioBiotechnology | SEC FORM 4 Code A | —5,900 at $0.00 | filing |
News
Scholar Rock Resubmits Marketing Authorisation Application For ApitegromabSRRK · rttnews.com · 8 Oct 2026
0 headlines in the last 90 days name Katie Peng; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.